EPGN and breast carcinoma: The epidermal growth factors epiregulin, epigen, and NRG1 are discovered to be downregulated as a result of pimozide’s inhibition of the phosphorylation of signal transducer and activator of transcription (STAT)5 in breast cancer cells [538].